In OSA patients, repeated oxygen desaturations and subsequent endothelial dysfunction induce the release of strong proinflammatory biomarkers, particularly tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP), leptin, and reactive oxygen species (ROS) (2–4). The gene discussed is IL6; the disease is endothelial dysfunction.